Lipocine Inc. (NASDAQ: LPCN), a biopharmaceutical company leveraging its proprietary technology platform to augment therapeutics through effective oral delivery, today announced positive data from its ...
The US Food and Drug Administration (FDA) recently approved a new medication treatmeant, called Cobenfy, which is a fundamentally new approach to treating schizophrenia. According to the World ...